Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial
All of the prospective multicenter trials that support the use of implantable defibrillators have used single chamber pacemakers/implantable cardiovertor defibrillators (ICDs). Despite the significantly increased cost of dual chamber pacemaker/ICD devices and the lack of outcome data, these devices...
Збережено в:
| Опубліковано в:: | Curr Control Trials Cardiovasc Med |
|---|---|
| Автор: | |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2001
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59522/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806799/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-5-215 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|